TL;DR: Cigna Healthcare modified MM 0084, its bone growth stimulator coverage policy, effective September 26, 2025. Here's what billing teams need to know about CPT 20975 and HCPCS E0760.
Cigna Healthcare updated Coverage Policy MM 0084 covering electrical and ultrasonic bone growth stimulators. The policy governs two codes: CPT 20975 for invasive electrical stimulation and HCPCS E0760 for low intensity ultrasound osteogenesis stimulators. Both codes carry medical necessity criteria, and billing either one without meeting those criteria is a fast path to claim denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Bone Growth Stimulators: Electrical (Invasive), Ultrasound |
| Policy Code | MM 0084 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | Medium |
| Specialties Affected | Orthopedic Surgery, Spine Surgery, Podiatry, Physical Medicine & Rehabilitation |
| Key Action | Audit current claims for CPT 20975 and HCPCS E0760 against updated medical necessity criteria before billing after September 26, 2025 |
Cigna Bone Growth Stimulator Coverage Criteria and Medical Necessity Requirements 2025
The Cigna bone growth stimulator coverage policy under MM 0084 addresses two distinct technologies. First, invasive electrical stimulation billed under CPT 20975. Second, low intensity ultrasound stimulation billed under HCPCS E0760 as durable medical equipment.
Both are considered medically necessary — but only when specific criteria are met. Cigna's language here is unambiguous: meeting criteria is a condition of coverage, not a suggestion. If your documentation doesn't support those criteria, you don't have a covered claim.
This matters most for orthopedic and spine billing teams. Bone growth stimulators typically enter the picture when standard fracture healing fails or when surgical fusion needs support. The clinical threshold for "failed healing" or "non-union" is where most claim denials originate — not from code selection errors, but from insufficient documentation of the underlying condition.
Prior authorization is a standard requirement for durable medical equipment benefits under most Cigna plans. HCPCS E0760, as a DME item, almost certainly falls under prior authorization review. Confirm this on the patient's specific plan before dispensing or billing. Skipping prior auth on E0760 is one of the most predictable sources of post-service denials in this category.
For CPT 20975, the invasive electrical stimulation procedure, authorization requirements depend on the site of service and plan type. Surgical procedures typically go through utilization management, so treat this as auth-required unless you've confirmed otherwise in writing from Cigna.
The real issue here is documentation. Cigna's coverage policy for bone growth stimulators hinges on clinical criteria that your referring physician or surgeon must substantiate in the medical record. Billing teams can't fix a documentation gap after the fact. Build your pre-authorization checklist around the criteria before the service happens.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Invasive electrical stimulation to aid bone healing | Covered when criteria are met | CPT 20975 | Operative procedure; prior auth likely required; medical necessity documentation required |
| Low intensity ultrasound osteogenesis stimulation, noninvasive | Covered when criteria are met | HCPCS E0760 | Billed as DME; prior authorization typically required; confirm plan-level DME benefits |
Cigna Bone Growth Stimulator Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Pull your MM 0084 criteria checklist before September 26, 2025. The effective date for this modification is September 26, 2025. Any claim for CPT 20975 or HCPCS E0760 submitted after that date falls under the updated policy. Audit your internal criteria checklist now and confirm it matches the current MM 0084 language at the Cigna source document. |
| 2 | Confirm prior authorization requirements for HCPCS E0760 on every active Cigna plan in your payer mix. HCPCS E0760 is a DME item. Cigna's DME prior authorization requirements vary by plan. Don't assume a commercial Cigna plan and a Cigna Medicare Advantage plan work the same way. Check each plan type separately. |
| 3 | Document the clinical basis for medical necessity before the service — not after. For bone growth stimulator billing, the documentation burden sits with the treating physician. Your billing team should have a pre-service checklist that captures non-union status, prior treatment history, and failed conservative management. A claim that reaches adjudication without this support will deny. |
| 4 | Update your charge capture for CPT 20975 to flag Cigna claims for documentation review. Invasive electrical stimulation under CPT 20975 is a surgical procedure. Build a charge capture workflow that routes Cigna claims for this code through a documentation review step before submission. One denied surgical claim costs more to work than an hour of front-end prevention. |
| 5 | Verify DME supplier credentials if billing E0760. HCPCS E0760 requires the billing entity to have valid DME supplier status. If your practice dispenses or arranges the ultrasound stimulator, confirm your DMEPOS accreditation and Cigna network status for DME specifically. This is separate from your professional billing relationship with Cigna. |
| 6 | Flag high-dollar bone growth stimulator cases for compliance review. Both CPT 20975 and HCPCS E0760 carry meaningful reimbursement. High-dollar codes under modified coverage policies attract audit attention. If you have volume in these codes, loop in your compliance officer to review your documentation standards before the September 26, 2025 effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Bone Growth Stimulators Under MM 0084
The policy data for MM 0084 includes two covered codes. The policy does not list specific ICD-10-CM diagnosis codes in the available data — but your team should ensure diagnoses reflect fracture non-union, delayed healing, or surgical fusion as appropriate to the clinical scenario.
Covered CPT Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 20975 | CPT | Electrical stimulation to aid bone healing; invasive (operative) |
Covered HCPCS Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| E0760 | HCPCS | Osteogenesis stimulator, low intensity ultrasound, noninvasive |
Key ICD-10-CM Diagnosis Codes
The MM 0084 policy data does not list specific ICD-10-CM codes. Bone growth stimulator billing typically pairs with diagnosis codes for fracture non-union, delayed healing, or spinal fusion indications. Work with your clinical team to confirm the appropriate diagnosis codes for each case. Using a vague or unspecified fracture code as the primary diagnosis on a bone growth stimulator claim is a common reason those claims go sideways at medical necessity review.
A Note on What This Policy Doesn't Tell Us
The available MM 0084 policy data confirms coverage positions for CPT 20975 and HCPCS E0760, but doesn't detail every specific medical necessity criterion in this summary. The full clinical criteria — including what constitutes non-union, how many months of failed healing are required, and what prior treatment history is necessary — live in the complete Cigna policy document.
Pull the full MM 0084 document directly from Cigna's coverage policy portal. Read the criteria section word for word. This is not a policy where approximation works. Cigna's bone growth stimulator coverage policy has specific clinical thresholds, and billing teams that work from summaries instead of the source document leave money on the table — or worse, submit claims that shouldn't have been submitted at all.
If your practice has significant volume in either CPT 20975 or HCPCS E0760, talk to your billing consultant or compliance officer before the September 26, 2025 effective date. The modification here may shift a threshold or add a documentation requirement that changes your approval rate.
Get the Full Picture for CPT 20975
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.